FGF1-mediated cardiomyocyte cell cycle reentry depends on the interaction of FGFR-1 and Fn14

FASEB Journal

Volumn 28, Issue 6, 2014, Pages 2492-2503

  Novoyatleva, Tatyana ^a   Sajjad, Amna ^a,b   Pogoryelov, Denys ^c   Patra, Chinmoy ^a   Schermuly, Ralph T ^d   Engel, Felix B ^a,e  

^a MAX PLANCK INSTITUTE FOR HEART AND LUNG RESEARCH   (Germany)

^b GOVERNMENT COLLEGE UNIVERSITY   (Pakistan)

^c GOETHE UNIVERSITY   (Germany)

^d JUSTUS LIEBIG UNIVERSITY   (Germany)

^e UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Heart; Signaling; TWEAK

Indexed keywords

CELL CYCLE PROTEIN; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTOR RECEPTOR 1; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN FN14; PROTEIN KINASE B; PROTEIN TWEAK; UNCLASSIFIED DRUG;

ADULT; ANIMAL CELL; ARTICLE; ASSAY; CELL CYCLE PROGRESSION; HEART MUSCLE CELL; IMMUNOPRECIPITATION; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN PROTEIN INTERACTION; PROXIMITY LIGATION ASSAY; RAT; SIGNAL TRANSDUCTION;

HEART; SIGNALING; TWEAK;

ANIMALS; APOPTOSIS REGULATORY PROTEINS; CELL CYCLE; CELL PROLIFERATION; FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTORS; MEMBRANE PROTEINS; MYOCYTES, CARDIAC; RATS; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 1; RECEPTORS, TUMOR NECROSIS FACTOR; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTORS;

EID: 84901819478     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.13-243576     Document Type: Article

References (66)

1. Itoh, N., and Ornitz, D. M. (2011) Fibroblast growth factors: from molecular evolution to roles in development, metabolism and disease. J. Biochem. 149, 121-130
2. Turner, N., and Grose, R. (2010) Fibroblast growth factor signalling: from development to cancer. Nat. Rev. Cancer 10, 116-129
3. Dell'Era, P., Ronca, R., Coco, L., Nicoli, S., Metra, M., and Presta, M. (2003) Fibroblast growth factor receptor-1 is essential for in vitro cardiomyocyte development. Circ. Res. 93, 414-420 (Pubitemid 37100006)
4. Steiling, H., and Werner, S. (2003) Fibroblast growth factors: key players in epithelial morphogenesis, repair and cytoprotection. Curr. Opin. Biotechnol. 14, 533-537 (Pubitemid 37298040)
5. Beenken, A., and Mohammadi, M. (2009) The FGF family: biology, pathophysiology and therapy. Nat. Rev. Drug Discov. 8, 235-253
6. Wilkie, A. O. (2005) Bad bones, absent smell, selfish testes: the pleiotropic consequences of human FGF receptor mutations. Cytokine Growth Factor Rev. 16, 187-203
7. Jin, Y., Pasumarthi, K. B., Bock, M. E., Lytras, A., Kardami, E., and Cattini, P. A. (1994) Cloning and expression of fibroblast growth factor receptor-1 isoforms in the mouse heart: evidence for isoform switching during heart development. J. Mol. Cell. Cardiol. 26, 1449-1459 (Pubitemid 24350154)
8. Liu, L., Pasumarthi, K. B., Padua, R. R., Massaeli, H., Fandrich, R. R., Pierce, G. N., Cattini, P. A., and Kardami, E. (1995) Adult cardiomyocytes express functional high-affinity receptors for basic fibroblast growth factor. Am. J. Physiol. 268, H1927-1938
9. Johnson, D. E., Lu, J., Chen, H., Werner, S., and Williams, L. T. (1991) The human fibroblast growth factor receptor genes: a common structural arrangement underlies the mechanisms for generating receptor forms that differ in their third immunoglobulin domain. Mol. Cell. Biol. 11, 4627-4634 (Pubitemid 21895859)
10. Pellieux, C., Foletti, A., Peduto, G., Aubert, J. F., Nussberger, J., Beermann, F., Brunner, H. R., and Pedrazzini, T. (2001) Dilated cardiomyopathy and impaired cardiac hypertrophic response to angiotensin II in mice lacking FGF-2. J. Clin. Invest. 108, 1843-1851 (Pubitemid 34015130)
11. Engelmann, G. L., Dionne, C. A., and Jaye, M. C. (1993) Acidic fibroblast growth factor and heart development. Role in myocyte proliferation and capillary angiogenesis. Circ. Res. 72, 7-19
12. Wanaka, A., Milbrandt, J., and Johnson, E. M., Jr. (1991) Expression of FGF receptor gene in rat development. Development 111, 455-468 (Pubitemid 21920428)
13. Lu, S. Y., Sheikh, F., Sheppard, P. C., Fresnoza, A., Duckworth, M. L., Detillieux, K. A., and Cattini, P. A. (2008) FGF-16 is required for embryonic heart development. Biochem. Biophys. Res. Commun. 373, 270-274
14. Marguerie, A., Bajolle, F., Zaffran, S., Brown, N. A., Dickson, C., Buckingham, M. E., and Kelly, R. G. (2006) Congenital heart defects in Fgfr2-IIIb and Fgf10 mutant mice. Cardiovasc. Res. 71, 50-60 (Pubitemid 43849677)
15. Sheikh, F., Fandrich, R. R., Kardami, E., and Cattini, P. A. (1999) Overexpression of long or short FGFR-1 results in FGF-2-mediated proliferation in neonatal cardiac myocyte cultures. Cardiovasc. Res. 42, 696-705 (Pubitemid 29298139)
16. Cuevas, P., Carceller, F., Lozano, R. M., Crespo, A., Zazo, M., and Gimenez-Gallego, G. (1997) Protection of rat myocardium by mitogenic and non-mitogenic fibroblast growth factor during post-ischemic reperfusion. Growth Factors 15, 29-40 (Pubitemid 27485256)
17. Engel, F. B., Hsieh, P. C., Lee, R. T., and Keating, M. T. (2006) FGF1/p38 MAP kinase inhibitor therapy induces cardiomyocyte mitosis, reduces scarring, and rescues function after myocardial infarction. Proc. Natl. Acad. Sci. U.S.A. 103, 15546-15551 (Pubitemid 44625629)
18. Kardami, E. (1990) Stimulation and inhibition of cardiac myocyte proliferation in vitro. Mol. Cell. Biochem. 92, 129-135
19. Engel, F. B., Schebesta, M., Duong, M. T., Lu, G., Ren, S., Madwed, J. B., Jiang, H., Wang, Y., and Keating, M. T. (2005) p38 MAP kinase inhibition enables proliferation of adult mammalian cardiomyocytes. Genes Dev. 19, 1175-1187 (Pubitemid 40696184)
20. Speir, E., Tanner, V., Gonzalez, A. M., Farris, J., Baird, A., and Casscells, W. (1992) Acidic and basic fibroblast growth factors in adult rat heart myocytes. Localization, regulation in culture, and effects on DNA synthesis. Circ. Res. 71, 251-259
21. Brown, S. A., Richards, C. M., Hanscom, H. N., Feng, S. L., and Winkles, J. A. (2003) The Fn14 cytoplasmic tail binds tumour-necrosis-factor-receptor- associated factors 1, 2, 3 and 5 and mediates nuclear factor-kappaB activation. Biochem. J. 371, 395-403 (Pubitemid 36547622)
22. Chorianopoulos, E., Heger, T., Lutz, M., Frank, D., Bea, F., Katus, H. A., and Frey, N. (2010) FGF-inducible 14-kDa protein (Fn14) is regulated via the RhoA/ROCK kinase pathway in cardiomyocytes and mediates nuclear factor-kappaB activation by TWEAK. Basic Res. Cardiol. 105, 301-313
23. Mustonen, E., Sakkinen, H., Tokola, H., Isopoussu, E., Aro, J., Leskinen, H., Ruskoaho, H., and Rysa, J. (2010) Tumour necrosis factor-like weak inducer of apoptosis (TWEAK) and its receptor Fn14 during cardiac remodelling in rats. Acta Physiol. 199, 11-22
24. Dogra, C., Changotra, H., Mohan, S., and Kumar, A. (2006) Tumor necrosis factor-like weak inducer of apoptosis inhibits skeletal myogenesis through sustained activation of nuclear factor-kappaB and degradation of MyoD protein. J. Biol. Chem. 281, 10327-10336 (Pubitemid 43864571)
25. Harada, N., Nakayama, M., Nakano, H., Fukuchi, Y., Yagita, H., and Okumura, K. (2002) Pro-inflammatory effect of TWEAK/Fn14 interaction on human umbilical vein endothelial cells. Biochem. Biophys. Res. Commun. 299, 488-493 (Pubitemid 35365656)
26. Novoyatleva, T., Diehl, F., van Amerongen, M. J., Patra, C., Ferrazzi, F., Bellazzi, R., and Engel, F. B. (2010) TWEAK is a positive regulator of cardiomyocyte proliferation. Cardiovasc. Res. 85, 681-690
27. Winkles, J. A. (2008) The TWEAK-Fn14 cytokine-receptor axis: discovery, biology and therapeutic targeting. Nat. Rev. Drug Discov. 7, 411-425
28. Bhatnagar, S., and Kumar, A. (2012) The TWEAK-Fn14 system: breaking the silence of cytokine-induced skeletal muscle wasting. Curr. Mol. Med. 12, 3-13
29. Donohue, P. J., Richards, C. M., Brown, S. A., Hanscom, H. N., Buschman, J., Thangada, S., Hla, T., Williams, M. S., and Winkles, J. A. (2003) TWEAK is an endothelial cell growth and chemotactic factor that also potentiates FGF-2 and VEGF-A mitogenic activity. Arterioscler. Thromb. Vasc. Biol. 23, 594-600 (Pubitemid 36438071)
30. Wiley, S. R., Cassiano, L., Lofton, T., Davis-Smith, T., Winkles, J. A., Lindner, V., Liu, H., Daniel, T. O., Smith, C. A., and Fanslow, W. C. (2001) A novel TNF receptor family member binds TWEAK and is implicated in angiogenesis. Immunity 15, 837-846 (Pubitemid 34008510)
31. Soonpaa, M. H., Kim, K. K., Pajak, L., Franklin, M., and Field, L. J. (1996) Cardiomyocyte DNA synthesis and binucleation during murine development. Am. J. Physiol. 271, H2183-2189
32. Faraone, D., Aguzzi, M. S., Ragone, G., Russo, K., Capogrossi, M. C., and Facchiano, A. (2006) Heterodimerization of FGFreceptor 1 and PDGF-receptor-alpha: a novel mechanism underlying the inhibitory effect of PDGF-BB on FGF-2 in human cells. Blood 107, 1896-1902 (Pubitemid 43289369)
33. Goetz, R., and Mohammadi, M. (2013) Exploring mechanisms of FGF signalling through the lens of structural biology. Nat. Rev. Mol. Cell. Biol. 14, 166-180
34. Furdui, C. M., Lew, E. D., Schlessinger, J., and Anderson, K. S. (2006) Autophosphorylation of FGFR1 kinase is mediated by a sequential and precisely ordered reaction. Mol. Cell 21, 711-717 (Pubitemid 43290737)
35. Engel, F. B., Hauck, L., Boehm, M., Nabel, E. G., Dietz, R., and von Harsdorf, R. (2003) p21(CIP1) Controls proliferating cell nuclear antigen level in adult cardiomyocytes. Mol. Cell. Biol. 23, 555-565 (Pubitemid 36050549)
36. Engel, F. B., Hauck, L., Cardoso, M. C., Leonhardt, H., Dietz, R., and von Harsdorf, R. (1999) A mammalian myocardial cell-free system to study cell cycle reentry in terminally differentiated cardiomyocytes. Circ. Res. 85, 294-301 (Pubitemid 29377302)
37. Tran, N. L., McDonough, W. S., Savitch, B. A., Sawyer, T. F., Winkles, J. A., and Berens, M. E. (2005) The tumor necrosis factor-like weak inducer of apoptosis (TWEAK)-fibroblast growth factor-inducible 14 (Fn14) signaling system regulates glioma cell survival via NFkappaB pathway activation and BCL-XL/BCL-W expression. J. Biol. Chem. 280, 3483-3492 (Pubitemid 40223813)
38. Ebelt, H., Hufnagel, N., Neuhaus, P., Neuhaus, H., Gajawada, P., Simm, A., Muller-Werdan, U., Werdan, K., and Braun, T. (2005) Divergent siblings: E2F2 and E2F4 but not E2F1 and E2F3 induce DNA synthesis in cardiomyocytes without activation of apoptosis. Circ. Res. 96, 509-517 (Pubitemid 40463459)
39. Poling, J., Szibor, M., Schimanski, S., Ingelmann, M. E., Rees, W., Gajawada, P., Kochfar, Z., Lorchner, H., Salwig, I., Shin, J. Y., Wiebe, K., Kubin, T., Warnecke, H., and Braun, T. (2011) Induction of smooth muscle cell migration during arteriogenesis is mediated by Rap2. Arterioscler. Thromb. Vasc. Biol. 31, 2297-2305
40. Gresch, O., Engel, F. B., Nesic, D., Tran, T. T., England, H. M., Hickman, E. S., Korner, I., Gan, L., Chen, S., Castro-Obregon, S., Hammermann, R., Wolf, J., Muller-Hartmann, H., Nix, M., Siebenkotten, G., Kraus, G., and Lun, K. (2004) New non-viral method for gene transfer into primary cells. Methods 33, 151-163 (Pubitemid 38569660)
41. Burkly, L. C., Michaelson, J. S., and Zheng, T. S. (2011) TWEAK/Fn14 pathway: an immunological switch for shaping tissue responses. Immunol. Rev. 244, 99-114
42. Baxter, F. O., Came, P. J., Abell, K., Kedjouar, B., Huth, M., Rajewsky, K., Pasparakis, M., and Watson, C. J. (2006) IKKbeta/2 induces TWEAK and apoptosis in mammary epithelial cells. Development 133, 3485-3494 (Pubitemid 44501850)
43. Weinberg, J. M. (2011) TWEAK-Fn14 as a mediator of acute kidney injury. Kidney Int. 79, 151-153
44. Zebrowski, D. C., and Engel, F. B. (2013) The cardiomyocyte cell cycle in hypertrophy, tissue homeostasis, and regeneration. Rev. Physiol. Biochem. Pharmacol. 165, 67-96
45. Szebenyi, G., and Fallon, J. F. (1999) Fibroblast growth factors as multifunctional signaling factors. Int. Rev. Cytol. 185, 45-106 (Pubitemid 129751072)
46. Bersell, K., Arab, S., Haring, B., and Kuhn, B. (2009) Neuregulin1/ErbB4 signaling induces cardiomyocyte proliferation and repair of heart injury. Cell 138, 257-270
47. Tseng, Y. T., Yano, N., Rojan, A., Stabila, J. P., McGonnigal, B. G., Ianus, V., Wadhawan, R., and Padbury, J. F. (2005) Ontogeny of phosphoinositide 3-kinase signaling in developing heart: effect of acute beta-adrenergic stimulation. Am. J. Physiol. Heart Circ. Physiol. 289, H1834-H1842 (Pubitemid 41507330)
48. Wajant, H. (2013) The TWEAK-Fn14 system as a potential drug target. Br. J. Pharmacol. 170, 748-764
49. Ornitz, D. M., Yayon, A., Flanagan, J. G., Svahn, C. M., Levi, E., and Leder, P. (1992) Heparin is required for cell-free binding of basic fibroblast growth factor to a soluble receptor and for mitogenesis in whole cells. Mol. Cell. Biol. 12, 240-247
50. Spivak-Kroizman, T., Lemmon, M. A., Dikic, I., Ladbury, J. E., Pinchasi, D., Huang, J., Jaye, M., Crumley, G., Schlessinger, J., and Lax, I. (1994) Heparin-induced oligomerization of FGF molecules is responsible for FGF receptor dimerization, activation, and cell proliferation. Cell 79, 1015-1024
51. Meighan-Mantha, R. L., Hsu, D. K., Guo, Y., Brown, S. A., Feng, S. L., Peifley, K. A., Alberts, G. F., Copeland, N. G., Gilbert, D. J., Jenkins, N. A., Richards, C. M., and Winkles, J. A. (1999) The mitogen-inducible Fn14 gene encodes a type I transmembrane protein that modulates fibroblast adhesion and migration. J. Biol. Chem. 274, 33166-33176 (Pubitemid 129535361)
52. Nissen, L. J., Cao, R., Hedlund, E. M., Wang, Z., Zhao, X., Wetterskog, D., Funa, K., Brakenhielm, E., and Cao, Y. (2007) Angiogenic factors FGF2 and PDGF-BB synergistically promote murine tumor neovascularization and metastasis. J. Clin. Invest. 117, 2766-2777 (Pubitemid 47529608)
53. Borroto-Escuela, D. O., Romero-Fernandez, W., Perez-Alea, M., Narvaez, M., Tarakanov, A. O., Mudo, G., Agnati, L. F., Ciruela, F., Belluardo, N., and Fuxe, K. (2012) The existence of FGFR1-5-HT1A receptor heterocomplexes in midbrain 5-HT neurons of the rat: relevance for neuroplasticity. J. Neurosci. 32, 6295-6303
54. Graves, L. M., Han, J., and Earp, H. S., 3rd (2002) Transactivation of the EGF receptor: is the PDGF receptor an unexpected accomplice? Mol. Interv. 2, 208-212
55. Saito, Y., Haendeler, J., Hojo, Y., Yamamoto, K., and Berk, B. C. (2001) Receptor heterodimerization: essential mechanism for platelet-derived growth factor-induced epidermal growth factor receptor transactivation. Mol. Cell. Biol. 21, 6387-6394 (Pubitemid 32927407)
56. Smyth, L. A., and Brady, H. J. (2005) cMet and Fas receptor interaction inhibits death-inducing signaling complex formation in endothelial cells. Hypertension 46, 100-106 (Pubitemid 40946498)
57. Gargano, N., Levi, A., and Alema, S. (1997) Modulation of nerve growth factor internalization by direct interaction between p75 and TrkA receptors. J. Neurosci. Res. 50, 1-12 (Pubitemid 27433347)
58. Hantzopoulos, P. A., Suri, C., Glass, D. J., Goldfarb, M. P., and Yancopoulos, G. D. (1994) The low affinity NGF receptor, p75, can collaborate with each of the Trks to potentiate functional responses to the neurotrophins. Neuron 13, 187-201 (Pubitemid 24238424)
59. Barker, P. A., and Shooter, E. M. (1994) Disruption of NGF binding to the low affinity neurotrophin receptor p75LNTR reduces NGF binding to TrkA on PC12 cells. Neuron 13, 203-215
60. Carey, D. J. (1997) Syndecans: multifunctional cell-surface coreceptors. Biochem. J. 327, 1-16
61. Woods, A., and Couchman, J. R. (1998) Syndecans: synergistic activators of cell adhesion. Trends Cell Biol. 8, 189-192 (Pubitemid 28188112)
62. Steinfeld, R., Van Den Berghe, H., and David, G. (1996) Stimulation of fibroblast growth factor receptor-1 occupancy and signaling by cell surface-associated syndecans and glypican. J. Cell Biol. 133, 405-416 (Pubitemid 26132538)
63. Eulalio, A., Mano, M., Ferro, M. D., Zentilin, L., Sinagra, G., Zacchigna, S., and Giacca, M. (2012) Functional screening identifies miRNAs inducing cardiac regeneration. Nature 492, 376-381
64. Mahmoud, A. I., Kocabas, F., Muralidhar, S. A., Kimura, W., Koura, A. S., Thet, S., Porrello, E. R., and Sadek, H. A. (2013) Meis1 regulates postnatal cardiomyocyte cell cycle arrest. Nature 497, 249-253
65. van Amerongen, M. J., and Engel, F. B. (2008) Features of cardiomyocyte proliferation and its potential for cardiac regeneration. J. Cell. Mol. Med. 12, 2233-2244
66. Alvarez, B., Martinez, A. C., Burgering, B. M., and Carrera, A. C. (2001) Forkhead transcription factors contribute to execution of the mitotic programme in mammals. Nature 413, 744-747 (Pubitemid 33009953)